SCHEMBL19366382

SCHEMBL19366382

CC1=C(C(=O)OC2CCCCC2)C(c2ccc(N=O)cc2)C2=C(CC(C)(C)CC2=O)N1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTCH1 P46531 5/20 0.75
CCNA2 P20248 1/20 0.75
CDK2 P24941 1/20 0.75
PSEN1 P49768 1/20 0.75
PSEN2 P49810 1/20 0.75
CCNA1 P78396 1/20 0.75
APH1B Q8WW43 1/20 0.75
NCSTN Q92542 1/20 0.75
APH1A Q96BI3 1/20 0.75
PSENEN Q9NZ42 1/20 0.75
KDM4E B2RXH2 13/20 0.67
ALDH1A1 P00352 11/20 0.67
TSHR P16473 5/20 0.67
NPSR1 Q6W5P4 3/20 0.67
HSD17B10 Q99714 3/20 0.67
TP53 P04637 1/20 0.66
GAA P10253 5/20 0.55
CASP1 P29466 3/20 0.55
RECQL P46063 1/20 0.55
RAB9A P51151 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16854538 0.90 NOTCH1 (0.81) NOTCH1CCNA2CDK2PSEN1PSEN2
SCHEMBL16854567 0.90 NOTCH1 (0.81) NOTCH1CCNA2CDK2PSEN1PSEN2
SCHEMBL15538182 0.89 NOTCH1 (0.79) NOTCH1CCNA2CDK2PSEN1PSEN2
SCHEMBL16854539 0.88 NOTCH1 (0.79) NOTCH1CCNA2CDK2PSEN1PSEN2
SCHEMBL3325137 0.87 NOTCH1 (0.76) NOTCH1CCNA2CDK2PSEN1PSEN2
SCHEMBL16850575 0.87 NOTCH1 (0.75) NOTCH1CCNA2CDK2PSEN1PSEN2
SCHEMBL15537264 0.87 NOTCH1 (0.80) NOTCH1CCNA2CDK2PSEN1PSEN2
SCHEMBL16854540 0.87 NOTCH1 (0.75) NOTCH1CCNA2CDK2PSEN1PSEN2
SCHEMBL15537010 0.87 NOTCH1 (0.75) NOTCH1CCNA2CDK2PSEN1PSEN2
SCHEMBL3326628 0.87 NOTCH1 (0.75) NOTCH1CCNA2CDK2PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017157825-A1 COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF SOLID TUMORS F. HOFFMANN-LA ROCHE AG (CH) 2017-09-21 WO disclosed